14
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Plasmodium falciparum Merozoite Vaccine in Aotus Monkeys: An Evaluation of the Tolerableness of Three Types of Adjuvants

, , &
Pages 393-402 | Published online: 29 Jul 2009

References

  • Anderson AO, Reynolds JA. Adjuvant effects of the lipid amine CP-20,961. J Reticuloendothel Soc 1979; 26: 667
  • Burgasow PN, Sumarokov AA, Lelikov VL, Marcuk LM, Fedenev VG, Džaparidze MN, Karaeva LT, Derteva II. Comparative study of reactions and serological response to cholera vaccines in a controlled field trial conducted in the USSR. Bull WHO 1976; 54: 163
  • Center for Disease Control. Rubella vaccine. Morb Mort Wkly Rep 1977; 26: 385
  • Center for Disease Control. DTP vaccine reactions—Montana. Morb Mort Wkly Rep 1978; 27: 471
  • Center for Disease Control. Plague vaccine. Morb Mort Wkly Rep 1978; 27: 255
  • Chapel HM, August PJ. Report of nine cases of accidental injury of man with Freund's complete adjuvant. Clin Exp Immunol 1976; 24: 538
  • Cohen S, Butcher GA, Mitchell GH. Immunization against erythrocytic forms of malaria parasites. Adv Exp Med Biol 1977; 93: 89
  • Desowitz RS, Miller LH. A perspective on malaria vaccines. Bull WHO 1980; 58: 897
  • Freund J. The mode of action of immunologic adjuvants. Adv Tuberc Res 1956; 7: 130
  • Gelder DW, Fisher S. Intradermal immunization. III. Typhoid fever. Am J Dis Child 1941; 62: 933
  • Ham TH, Curtis FC. Plasma fibrinogen response in man. Influence of the nutritional state, induced hyperpyrexia, infectious disease and liver damage. Medicine 1938; 17: 413
  • Heidelberger M, Coates WA, Mayer MM. Studies in human malaria. II. Attempts to influence relapsing vivax malaria by treatment of patients with vaccine. J Immunol 1946; 53: 101
  • Heymann W, Hackel D, Harwood S, Wilson S, Hunter J. Production of nephrotic syndrome in rats by Freund's adjuvant and rat kidney suspension. Proc Soc Exp Biol Med 1959; 100: 660
  • Hoffman WW, Korst JJ, Niblack JF, Cronin TH. N,N-dioctadecyl-N1, N1-bis (2-hydroxyethyl) propanediamine: antiviral activity and interferon stimulation in mice. Antimicrob Agents Chemother 1973; 3: 498
  • Koivisto M, Brander E, Hakosalo J, Wasz-Höckert O. A comparative study of three BCG-vaccines. Duodecim 1974; 90: 1717
  • Kotani S, Watanabe J, Kinoshita F, Shimono T, Morisaki I, Shiba T, Kusumoto S, Tarumi Y, Ikenaka K. Immunoadjuvant activities of synthetic N-acetylmuramyl-peptides or amino acids. Biken J 1975; 18: 105
  • Kotani S, Takada H, Tsujimoto M, Ogawa T, Kato K, Okunaga T, Ishihara Y, Kawasaki A, Morisaki I, Kono N, Shimono T, Shiba T, Kusumoto S, Inage M, Harada K, Kitaura T, Kano S, Inai S, Nagai K, Matsumoto M, Kubo T, Kato M, Tada Z, Yokogawa K, Kawata S, Inoue A. Immunomodulating and related biological activities of bacterial cell walls and their components, enzymatically prepared or synthesized. Immuno-modulation by bacteria and their products, H Friedman, TW Klein, A Szentivanyi. Plenum Press, New York 1981; 231
  • Lepine A. Reactions to injections of different volumes. Lancet 1961; 1: 333
  • Mitchell GH, Butcher GA, Richards W HG, Cohen S. Merozoite vaccination of Douroucouli monkeys against falciparum malaria. Lancet 1977; 1: 1335
  • Mizuhara H, Murata R. Diphtheria. The vaccination, H Fukumi. International Medical Foundation of Japan, Tokyo 1975; 83
  • Niblack JF, Otterness IG, Hemsworth GR, Wolff JS, Hoffman WW, Kraska AR. CP-20,961: a structurally novel, synthetic adjuvant. J Reticuloendothel Soc 1979; 26: 655
  • Noble JE, Fielding P. Combined enteric and cholera vaccination by the intradermal route. J Hyg (Camb) 1965; 63: 345
  • Panusarn C, Stanley ED, Dirda V, Rubenis M, Jackson GG. Prevention of illness from rhinovirus infection by a topical interferon inducer. N Engl J Med 1974; 291: 57
  • Peltola H, Ruutu P, Palomäki H, Kaukinen K, Aho K. Intracutaneous vaccination technique—a review and some own observations. Duodecim 1977; 93: 431
  • Peltola HO, Case SE, Perri SF, Siddiqui WA. Plasmodium falciparum merozoite vaccination in Aotus monkeys recovered spontaneously from P. falciparum infection: a clinical study. Scand J Infect Dis 1982; 14: 217
  • Peltola HO, Case SE, Perri SF, Siddiqui WA. Reactogenicity of a malarria merozoite antigen in Aotus monkeys compared with the effects caused by two new adjuvants, CP-20,961 and [B30]-MDP. Scand J Infect Dis 1983; 15: 383
  • Perry RM. Comparison of typhoid “O” and “H” agglutinin responses following intracutaneous and subcutaneous inoculation of typhoid, paratyphoid A and B vaccine. Am J Hyg 1937; 26: 388
  • Robertson PW, Leonard BJ. Some delayed complications of inoculation. Br Med J 1956; 2: 1029
  • Siddiqui WA. An effective immunization of experimental monkeys against a human malaria parasite, Plasmodium falciparum. Science 1977; 197: 388
  • Siddiqui WA, Kan SC, Kramer K, Richmond-Crum SM. In-vitro production and partial purification of Plasmodium falciparum antigen. Bull WHO 1979; 57: 75
  • Siddiqui WA. Immunization against asexual blood-inhabiting stages of Plasmodia. Malaria, vol 3, JP Kreier. Academic Press, New York 1980; 231
  • Siddiqui WA, Kan SC, Kramer K, Case S, Palmer K. Use of synthetic adjuvant in an effective vaccination of monkeys against malaria. Nature 1981; 289: 64
  • Singer E, Wei SH, Hoa SH. Cholera immunization. J Immunol 1948; 60: 181
  • Steblay RW. Glomerulonephritis induced in monkeys by injection of heterologous glomerular basement membrane and Freund's adjuvant. Nature 1963; 197: 1173
  • Targett G AT, Fulton JD. Immunization of rhesus monkeys against Plasmodium knowlesi malaria. Exp Parasitol 1965; 17: 180
  • Tuft L. Active immunization against typhoid fever, with particular reference to an intradermal method. J Lab Clin Med 1931; 16: 552
  • Volk VK, Top FH, Bunney WE. Significance of “cysts” following injections of antigens. Am J Public Health 1954; 44: 1314
  • Wycoff HD. Production of fibrinogen following an endotoxin injection (34599). Proc Soc Exp Biol Med 1970; 133: 940
  • Yü-T'u C, Ch'en T-H. Reaction and immune response to typhoid and paratyphoid vaccines of different dosage and routes of injection. Chin Med J 1958; 76: 47

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.